Arbutus Biopharma Corp (ABUS)

전일 마감가:

$2.68

열려 있는:

$2.71

하루 거래량:

678.62K

시가총액:

$488.27M

수익:

$18.14M

순이익/손실:

$-72.85M

주가수익비율:

-5.8913

EPS:

-0.46

순현금흐름:

$-86.94M

1주 성능:

-0.73%

1개월 성능:

-7.19%

6개월 성능:

+41.15%

1년 성능:

+7.97%

1일 변동 폭

$2.70

$2.85

52주 변동 폭

$1.69

$3.29

Arbutus Biopharma Corp Stock (ABUS) Company Profile

명칭

Arbutus Biopharma Corp

부문

Healthcare (1221)

산업

Biotechnology (699)

전화

604-419-3200

주소

100-8900 Glenlyon Parkway, Burnaby, PA

직원

130

트위터

@arbutusbio

다음 수익 날짜

2024-05-22

최신 SEC 제출 서류

ABUS's Discussions on Twitter

Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-02-02	업그레이드	Jefferies	Hold → Buy
2021-02-25	개시	Jefferies	Hold
2020-12-17	개시	H.C. Wainwright	Buy
2020-07-27	재개	JMP Securities	Mkt Outperform
2020-07-24	다운그레이드	Robert W. Baird	Outperform → Neutral
2020-05-19	업그레이드	Wedbush	Neutral → Outperform
2020-03-06	업그레이드	Chardan Capital Markets	Neutral → Buy
2020-02-20	개시	Robert W. Baird	Outperform
2020-02-05	업그레이드	JMP Securities	Mkt Perform → Mkt Outperform
2019-10-07	재확인	B. Riley FBR	Buy
2019-10-04	다운그레이드	Chardan Capital Markets	Buy → Neutral
2018-10-16	업그레이드	B. Riley FBR	Neutral → Buy
2018-10-15	업그레이드	Wedbush	Underperform → Neutral
2018-10-12	재확인	Chardan Capital Markets	Buy
2018-07-06	다운그레이드	B. Riley FBR, Inc.	Buy → Neutral
2018-03-19	재개	Chardan Capital Markets	Buy
2018-03-19	다운그레이드	Wedbush	Outperform → Neutral
2018-01-05	개시	B. Riley FBR, Inc.	Buy
2017-04-04	업그레이드	Chardan Capital Markets	Neutral → Buy
2017-02-01	재확인	Wedbush	Outperform
2016-12-13	다운그레이드	Chardan Capital Markets	Buy → Neutral
2016-11-30	업그레이드	Chardan Capital Markets	Neutral → Buy

모두보기

Arbutus Biopharma Corp 주식(ABUS)의 최신 뉴스

Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

GlobeNewswire Inc.

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

Zacks Investment Research

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire Inc.

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna

GlobeNewswire Inc.

Arbutus to Participate in Two Upcoming Investor Conferences

GlobeNewswire Inc.

Arbutus Biopharma Corp (ABUS) 재무 분석

Arbutus Biopharma Corp (ABUS) 매출 2024

Arbutus Biopharma Corp (ABUS) 순이익 2024

Arbutus Biopharma Corp (ABUS) 현금흐름 2024

Arbutus Biopharma Corp (ABUS) 주당 순이익 2024